LOS ANGELES, Nov. 26, 2025 (GLOBE NEWSWIRE) -- The Schall Law Firm, a national shareholder rights litigation firm, announces that it is investigating claims on behalf of investors of Alector, Inc. (“Alector” or “the Company”) (NASDAQ: ALEC) for violations of the securities laws. The investigation focuses on whether the Company issued false and/or misleading statements and/or failed to disclose information pertinent to investors.

LAFOX, Ill., Nov. 26, 2025 (GLOBE NEWSWIRE) -- Richardson Electronics, Ltd. (NASDAQ: RELL), a global provider of engineered solutions for alternative energy, power management, and custom display markets, today announced that Edward J. Richardson, Chairman and CEO and Wendy Diddell, COO of Richardson Electronics, Ltd., will be attending and hosting one-on-one meetings at the Benchmark 14th Annual Discovery One-on-One Investor Conference being held at The New York Athletic Club on December 4, 2025.

NEW YORK, NY / ACCESS Newswire / November 26, 2025 / There are moments when an industry realizes the ground beneath it is shifting. Yesterday at the 2025 DMCC Precious Metals Conference, that moment arrived.

Mark Mahaney, head of internet research at Evercore ISI, joins CNBC's ‘Squawk on the Street' to discuss Alphabet as the tech giant's stock surges to all-time highs, the ongoing AI race, and more.

Akamai Technologies, Inc. (AKAM) is looking like an interesting pick from a technical perspective, as the company reached a key level of support. Recently, AKAM's 50-day simple moving average crossed above its 200-day simple moving average, known as a "golden cross.

The consensus price target hints at a 26.4% upside potential for Orion Energy Systems (OESX). While empirical research shows that this sought-after metric is hardly effective, an upward trend in earnings estimate revisions could mean that the stock will witness an upside in the near term.

ClearSign (CLIR) witnesses a hammer chart pattern, indicating support found by the stock after losing some value lately. This coupled with an upward trend in earnings estimate revisions could mean a trend reversal for the stock in the near term.

From a technical perspective, PLBY Group, Inc. (PLBY) is looking like an interesting pick, as it just reached a key level of support. PLBY's 50-day simple moving average crossed above its 200-day simple moving average, which is known as a "golden cross" in the trading world.

The consensus price target hints at a 34.2% upside potential for Keros Therapeutics (KROS). While empirical research shows that this sought-after metric is hardly effective, an upward trend in earnings estimate revisions could mean that the stock will witness an upside in the near term.

The mean of analysts' price targets for Immuneering (IMRX) points to a 126.2% upside in the stock. While this highly sought-after metric has not proven reasonably effective, strong agreement among analysts in raising earnings estimates does indicate an upside in the stock.

The mean of analysts' price targets for Life Time Group Holdings (LTH) points to a 46.6% upside in the stock. While this highly sought-after metric has not proven reasonably effective, strong agreement among analysts in raising earnings estimates does indicate an upside in the stock.

The mean of analysts' price targets for Pharming Group (PHAR) points to an 81.7% upside in the stock. While this highly sought-after metric has not proven reasonably effective, strong agreement among analysts in raising earnings estimates does indicate an upside in the stock.

The average of price targets set by Wall Street analysts indicates a potential upside of 26.5% in OrthoPediatrics (KIDS). While the effectiveness of this highly sought-after metric is questionable, the positive trend in earnings estimate revisions might translate into an upside in the stock.

The mean of analysts' price targets for SkyWest (SKYW) points to a 34.5% upside in the stock. While this highly sought-after metric has not proven reasonably effective, strong agreement among analysts in raising earnings estimates does indicate an upside in the stock.

The average of price targets set by Wall Street analysts indicates a potential upside of 58.5% in Amicus Therapeutics (FOLD). While the effectiveness of this highly sought-after metric is questionable, the positive trend in earnings estimate revisions might translate into an upside in the stock.

The mean of analysts' price targets for Compass Therapeutics, Inc. (CMPX) points to a 154.1% upside in the stock. While this highly sought-after metric has not proven reasonably effective, strong agreement among analysts in raising earnings estimates does indicate an upside in the stock.

The average of price targets set by Wall Street analysts indicates a potential upside of 27.9% in Crexendo (CXDO). While the effectiveness of this highly sought-after metric is questionable, the positive trend in earnings estimate revisions might translate into an upside in the stock.

The mean of analysts' price targets for PRA Group (PRAA) points to a 42% upside in the stock. While this highly sought-after metric has not proven reasonably effective, strong agreement among analysts in raising earnings estimates does indicate an upside in the stock.

The mean of analysts' price targets for Abacus Life, Inc. (ABL) points to an 110.3% upside in the stock. While this highly sought-after metric has not proven reasonably effective, strong agreement among analysts in raising earnings estimates does indicate an upside in the stock.

Shares of Deere & Company (DE) fell Wednesday morning after the maker of large farm and construction equipment gave a weak forecast and warned that “difficult market conditions” will continue for a while longer.